BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33752449)

  • 1. Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial.
    Wang A; Gerstein HC; Lee SF; Hess S; Paré G; Rydén L; Mellbin LG
    Diab Vasc Dis Res; 2021; 18(2):14791641211002475. PubMed ID: 33752449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial.
    Wang A; Arver S; Boman K; Gerstein HC; Fu Lee S; Hess S; Rydén L; Mellbin LG
    Eur J Prev Cardiol; 2019 May; 26(8):847-854. PubMed ID: 30567457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of sex hormone-binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes.
    Ramachandran S; Strange RC; Fryer AA; Saad F; Hackett GI
    Andrology; 2018 Nov; 6(6):846-853. PubMed ID: 30006962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trial.
    Wang A; Hess S; Lee SF; Gerstein HC
    Diabetes Res Clin Pract; 2023 Dec; 206():111010. PubMed ID: 37956942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.
    Papademetriou V; Nylen ES; Doumas M; Probstfield J; Mann JFE; Gilbert RE; Gerstein HC
    Am J Med; 2017 Dec; 130(12):1465.e27-1465.e39. PubMed ID: 28842165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men.
    Yeap BB; Marriott RJ; Antonio L; Chan YX; Raj S; Dwivedi G; Reid CM; Anawalt BD; Bhasin S; Dobs AS; Hankey GJ; Matsumoto AM; Norman PE; O'Neill TW; Ohlsson C; Orwoll ES; Vanderschueren D; Wittert GA; Wu FCW; Murray K
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e625-e637. PubMed ID: 33059368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of sex hormone-binding globulin and free testosterone with mortality in men with type 2 diabetes mellitus.
    Tint AN; Hoermann R; Wong H; Ekinci EI; MacIsaac RJ; Jerums G; Zajac JD; Grossmann M
    Eur J Endocrinol; 2016 Jan; 174(1):59-68. PubMed ID: 26483395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14.
    Pratley RE; Husain M; Lingvay I; Pieber TR; Mark T; Saevereid HA; Møller DV; Zinman B;
    Cardiovasc Diabetol; 2019 Nov; 18(1):156. PubMed ID: 31729990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study.
    Goto A; Morita A; Goto M; Sasaki S; Miyachi M; Aiba N; Terauchi Y; Noda M; Watanabe S;
    Cardiovasc Diabetol; 2012 Oct; 11():130. PubMed ID: 23066943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
    Zhao D; Guallar E; Ouyang P; Subramanya V; Vaidya D; Ndumele CE; Lima JA; Allison MA; Shah SJ; Bertoni AG; Budoff MJ; Post WS; Michos ED
    J Am Coll Cardiol; 2018 Jun; 71(22):2555-2566. PubMed ID: 29852978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
    Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia.
    Gerstein HC; Paré G; McQueen MJ; Haenel H; Lee SF; Pogue J; Maggioni AP; Yusuf S; Hess S;
    Circulation; 2015 Dec; 132(24):2297-304. PubMed ID: 26518765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone, Dihydrotestosterone, Sex Hormone-Binding Globulin, and Incident Diabetes Among Older Men: The Cardiovascular Health Study.
    Joyce KE; Biggs ML; Djoussé L; Ix JH; Kizer JR; Siscovick DS; Shores MM; Matsumoto AM; Mukamal KJ
    J Clin Endocrinol Metab; 2017 Jan; 102(1):33-39. PubMed ID: 27732332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of endogenous sex hormone levels with coronary artery calcium progression among post-menopausal women in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Subramanya V; Zhao D; Ouyang P; Ying W; Vaidya D; Ndumele CE; Heckbert SR; Budoff MJ; Post WS; Michos ED
    J Cardiovasc Comput Tomogr; 2019; 13(1):41-47. PubMed ID: 30297127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal insulin and cardiovascular and other outcomes in dysglycemia.
    ; Gerstein HC; Bosch J; Dagenais GR; Díaz R; Jung H; Maggioni AP; Pogue J; Probstfield J; Ramachandran A; Riddle MC; Rydén LE; Yusuf S
    N Engl J Med; 2012 Jul; 367(4):319-28. PubMed ID: 22686416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and the risk of type 2 diabetes mellitus: A 9-year follow up among elderly men in Finland.
    Salminen M; Vahlberg T; Räihä I; Niskanen L; Kivelä SL; Irjala K
    Geriatr Gerontol Int; 2015 May; 15(5):559-64. PubMed ID: 24891075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.
    Tibblin G; Adlerberth A; Lindstedt G; Björntorp P
    Diabetes; 1996 Nov; 45(11):1605-9. PubMed ID: 8866567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.